Theravance Biopharma Inc. appointed Laurie Alsup as an independent director.
Alsup is the COO and chief scientific officer of NDA Group.
Theravance Biopharma adds independent director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Theravance Biopharma Inc. appointed Laurie Alsup as an independent director.
Alsup is the COO and chief scientific officer of NDA Group.